L Alexa Thompson
Overview
Explore the profile of L Alexa Thompson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
39
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Thompson L, Plitt S, Zhuo R, Charlton C
Can Liver J
. 2024 May;
7(2):273-285.
PMID: 38746866
Background: Prior to the COVID-19 pandemic, Alberta was on track to meet national HCV elimination targets by 2030. However, it is unclear how the pandemic has affected progress. Here, we...
2.
3.
Blaz J, Galindo L, Heiss A, Kaur H, Torruella G, Yang A, et al.
Sci Data
. 2023 Sep;
10(1):603.
PMID: 37689692
Mantamonads were long considered to represent an "orphan" lineage in the tree of eukaryotes, likely branching near the most frequently assumed position for the root of eukaryotes. Recent phylogenomic analyses...
4.
Thompson L, Plitt S, Doucette K, Coffin C, Klein K, Robinson J, et al.
J Hepatol
. 2023 Jun;
79(5):1121-1128.
PMID: 37348788
Background & Aims: Canadian clinical practice guidelines currently recommend risk-based screening for HCV in pregnant individuals. However, no provinces or territories have ever compared the effectiveness of risk-based vs. universal...
5.
Charlton C, Bailey A, Thompson L, Kanji J, Marshall N
Vaccine
. 2023 Mar;
41(17):2734-2738.
PMID: 36948982
Objectives: To assess the guideline concordance of medical school requirements for students' proof-of-immunity in the United States (US) and Canada. Methods: National guidelines for healthcare worker proof-of-immunity to measles, mumps,...
6.
Thompson L, Plitt S, Gratrix J, Charlton C
Can Liver J
. 2023 Mar;
6(1):70-75.
PMID: 36908571
Alberta routinely screens pregnant patients for select communicable diseases. Hepatitis C virus (HCV) was added to the prenatal screening panel as part of a provincial pilot program in February 2020....
7.
Thompson L, Fenton J, Charlton C
J Assoc Med Microbiol Infect Dis Can
. 2022 Nov;
7(2):97-107.
PMID: 36337352
Background: Hepatitis C virus (HCV) can be cured with antiviral treatments. Diagnosis normally requires two blood samples, one for serology screening and one for molecular confirmation. This multi-step process creates...
8.
Zhuo R, Charlton C, Plitt S, Thompson L, Braun S, Day J, et al.
J Clin Virol
. 2022 Sep;
156:105292.
PMID: 36108404
The accurate measurement of serological response to SARS-CoV-2 vaccination is needed to correlate responses with effective protective immunity. The World Health Organization (WHO) has created an international standard to allow...
9.
Mukherjee A, Crochetiere M, Sergerie A, Amiar S, Thompson L, Ebrahimzadeh Z, et al.
mBio
. 2022 Jan;
13(1):e0323921.
PMID: 35038916
Phosphoinositide lipids play key roles in a variety of processes in eukaryotic cells, but our understanding of their functions in the malaria parasite Plasmodium falciparum is still very much limited....
10.
Ma A, Thompson L, Corsiatto T, Hurteau D, Tyrrell G
Microbiol Spectr
. 2021 Nov;
9(3):e0128321.
PMID: 34762517
Group B Streptococcus (GBS) is a leading cause of invasive neonatal disease. Epidemiological surveillance of GBS is important to determine cumulative incidence, antimicrobial resistance rates, and maternal and neonatal disease...